ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.25
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.25 1.10 1.40 1.25 1.25 1.25 592,472 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -3.57 1.69M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.25p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £1.69 million. Physiomics has a price to earnings ratio (PE ratio) of -3.57.

Physiomics Share Discussion Threads

Showing 21551 to 21568 of 30150 messages
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older
DateSubjectAuthorDiscuss
21/5/2018
13:49
Dave....just for cancer? The disease that one in two of us WILL experience in our lifetimes......that's really uncommon isnt it Dave? Good grief....if you are going to be a troll at least make your argument sensible.
coldspring
21/5/2018
13:39
Because the government wants to use ai for ALL ILLNESSES, and all pyc does is model dosage predictions for trials, just for cancer drugs. Hence why they will need to use companies that cover as many bases as possible, like Oxford Bio, based in OXFORD, as you just mention, who have a plethora of advanced simulation systems for many drugs and diseases, actually modelling for the design, not just for mere dosing.
davevt
21/5/2018
13:29
It's incredible, the Government has come out with a MASSIVE Industrial Strategy initiative to invest in jobs and tech in this Country in Precision Medicine and AI which is pretty much solely focused around Oxford (i.e. PYC) and nobody seems to have picked up on it!

Here are the clues for the hard of thinking :-

PYC have been talking about Precision Medicine, Big Data, Cloud and AI

PYC have now had multiple contracts from the Government for Precision Medicine focused on Cancer treatments

PYC are currently pitching for more contracts with the Government in Precision Medicine/AI arena

PYC are working with Government/Oxford Uni/Cancer Research UK/Oxford NHS etc on a CANCER DSS tool to help improve cancer treatments

PYC is the future and you can buy the Company right now for £3m when its peers are valued at hundreds of millions and billions !

the stigologist
21/5/2018
11:31
And with a ridiculous liw valuation!!!
billthebank
21/5/2018
11:23
Agreed, could be a great link? How many companies available to buy stock in that are in this area? ;)
margic
21/5/2018
10:07
Stig, it says treatable illnesses, not cancer, so once again why would you think pyc would get a look in when they only do dosage modelling for drug trials for cancer drugs, and all the other big companies you keep mentioning like OXFORD biometrics do a.i design for loads of drugs for loads of ILLNESSES.?
davevt
21/5/2018
09:41
Physiomics KLAXON
Physiomics KLAXON

!!!!
The Prime Minister is expected to say:

Late diagnosis of otherwise treatable illnesses is one of the biggest causes of avoidable deaths.

And the development of smart technologies to analyse great quantities of data quickly and with a higher degree of accuracy than is possible by human beings opens up a whole new field of medical research and gives us a new weapon in our armoury in the fight against disease.

Achieving this mission will not only save thousands of lives. It will incubate a whole new industry around AI-in-healthcare, creating high-skilled science jobs across the country, drawing on existing centres of excellence in places like Edinburgh, Oxford and Leeds – and helping to grow new ones.

the stigologist
21/5/2018
09:38
there is some big news coming our way folks

Physiomics doing their marketing roadshow

Government talking about funding for data and AI

We are waiting for at least one funding round from Govt but I expect more on top

the stigologist
21/5/2018
08:53
Uh oh, Stig is trying to ramp like hell again. If ai for cancer is the next big thing, why do you think they would bother with pyc who only do dosage modelling and not go straight to all the Mega behemoth ai companies YOU KEEP MENTIONING in your posts that are the leaders in their field and worth tens to hundreds of millions. Give one reason why pyc would even get a look in?
davevt
21/5/2018
06:23
BBC the FT the Times

Theresa May the Prime Minister saying AI to deal with Cancer

Massive massive news and contracts coming for PYC I bet

the stigologist
21/5/2018
06:22
It's everywhere!!!
the stigologist
20/5/2018
22:22
Just got to look at any basic 3month chart as a novice or pro. The move out to one year for first target highs. Thinking a good run starts this week onwards, I reckon it will be quick and with any luck harsh, stock building profit taking opportunity araising imo. A bit of news momentum would be nice, I'm more hoping on volume and price movement to kick off. That's what will trigger value for all here. Time to start warming up.
margic
20/5/2018
08:40
6p is not the new 1p. 6p is the residual left from the 32p it soared to last November. Conscious of the inevitable drop back to 2p they release news whenever they can no matter how vacuous. In the old days they would have been too ashamed to release news detailing a £48k contract. But today to prop up a worthless AIM stock investors need news, news and more news.
pwhite73
19/5/2018
11:56
6p is the new 1p
News from this base should see the rise to 50-100p where this belongs

the stigologist
19/5/2018
11:54
Shareholder base seems to be improving
the stigologist
17/5/2018
12:30
500k contract RnS???
spacedust
16/5/2018
09:13
Calm before the storm here. Let's see what the company says when they release their results
billthebank
16/5/2018
08:30
5m is a lot when pyc charge 35k per drug modelling service. Basically what you're hoping for is some brand new pharma is gonna pop up with 150 cancer drugs to test lol. Never gonna happen. They might have one or two drugs a year, or if they've already been a customer for years, progressed onto clinical trials which commands a bit more money. But you can't quote pie in the sky figures that don't add up to the services charged.
davevt
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older

Your Recent History

Delayed Upgrade Clock